Suchergebnisse - "Mu, Guangyan"

PubPharm (85)

71

A potential role for theCDH13/CDH15gene in repeat revascularization after first percutaneous coronary intervention

enthalten in: Pharmacogenomics | 2019

von Xiang, Q. | Liu, Z. | Lu, Y. | +10

72

Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis

enthalten in: Current drug metabolism | 2019

von Zhou, S. | Xiang, Q. | Mu, G. | +5

73

Candidate gene and pathway analyses identifying genetic variations associated with prasugrel pharmacokinetics and pharmacodynamics

enthalten in: Thrombosis research | 2019

von Liu, Z. | Xiang, Q. | Zhao, X. | +9

74

Association of dopamine D2 receptor gene polymorphisms with prolactin levels related to risperidone treatment : A systematic review and meta‐analysis

enthalten in: Journal of clinical pharmacy and therapeutics | 2019

von Ma, L. | Xiang, Q. | Zhou, S. | +9

75

The association between the SLCO1B1, apolipoprotein E, and CYP2C9 genes and lipid response to fluvastatin : a meta-analysis

enthalten in: Pharmacogenetics and genomics | 2018

von Xiang, Q. | Zhang, X. | Ma, L. | +6

76

Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer : a systematic review and meta-analysis

enthalten in: Breast cancer research and treatment | 2018

von Zhang, Z. | Li, C. | Fan, H. | +8

77

XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy : A systematic review and MOOSE-compliant meta-analysis

enthalten in: Medicine | 2018

von Zhang, Z. | Xiang, Q. | Mu, G. | +5

78

Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches

enthalten in: RSC advances | 2018

von Pang, X. | Zhang, B. | Mu, G. | +6

79

Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis

enthalten in: Breast cancer research and treatment | 2018

von Zhang, Z. | Li, C. | Fan, H. | +8

80

Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis

enthalten in: Breast cancer research and treatment | 2018

von Zhang, Z. | Li, C. | Fan, H. | +8